Alerts will be sent to your verified email
Verify Email
LAURUSLABS
|
Laurus Labs
|
Neuland Laboratories
|
Granules India
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.77 % | 14.95 % | 17.11 % |
|
5yr Avg Net Profit Margin
|
11.95 % | 13.18 % | 11.91 % |
|
Price to Book
|
10.38 | 11.27 | 3.36 |
|
P/E
|
91.26 | 97.59 | 26.07 |
|
5yr Avg Cash Conversion Cycle
|
91.73 Days | 38.21 Days | -44.08 Days |
|
5yr Average Interest Coverage Ratio
|
8.98 | 20.78 | 15.94 |
|
5yr Avg ROCE
|
22.73 % | 17.63 % | 21.96 % |
|
5yr Avg Operating Profit Margin
|
24.36 % | 21.01 % | 21.18 % |
|
5 yr average Debt to Equity
|
0.56 | 0.15 | 0.38 |
|
5yr CAGR Net Profit
|
-18.29 % | 26.4 % | -1.81 % |
|
5yr Average Return on Assets
|
8.99 % | 9.87 % | 10.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
27.59 % | 32.68 % | 38.82 % |
|
Share Pledged by Promoters
|
2.69 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.32 % | -3.54 % | -3.16 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.01 % | 6.87 % | 9.21 % |
|
Laurus Labs
|
Neuland Laboratories
|
Granules India
|
|---|